ArticleHeart rhythm O22026
Beyond symptoms: Rhythm surveillance in congenital heart disease.
Article in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with congenital heart disease (CHD) face a lifelong risk of arrhythmias, many of which remain asymptomatic and undetected. Objective: This study aimed to evaluate the diagnostic yield of different rhythm surveillance strategies, assess symptom-arrhythmia correlation, and determine the clinical value of arrhythmia screening in patients with CHD. Methods: We retrospectively analyzed 552 patients with CHD (66.1% female; median age 34 years) who underwent 7-day patch rhythm monitoring at a tertiary center between December 2022 and January 2025. Patients were grouped as symptomatic or asymptomatic (screening). The patch device also functioned as an event recorder, with the first 24 hours analyzed as standard Holter monitoring. Results: The symptomatic group consisted of 349 patients, and the screening group consisted of 203 patients. Any arrhythmias were detected in 64.8% of symptomatic and 68.5% of screening group ( Conclusion: Arrhythmias in CHD are common, age dependent, and poorly predicted by symptoms. Prolonged monitoring enhances detection and guides management, supporting risk-stratified surveillance based on age and disease complexity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.